ASBISc Enterprises Plc Invests in biotech developing novel dermaceuticals to alleviate skin side effects of cancer treatment.

RSL Revolutionary Labs Ltd, a healthcare-focused biotech company offering unique skincare formulations designed to treat unmet needs of oncology patients, has received a €700K investment from ASBIS Enterprises Plc.

The investment will be used to enhance the continuous efforts to develop innovative products and formulations for the needs of oncology patients. RSL Revolutionary Labs is now entering multi-centered clinical trials with new products that are based on novel collagen formulations able to heal severe medical wounds effectively. The funding will also be used to scale up production capacity in the state-of-the-art facilities housed in the brand new ASBIS Ηi-Τech Cluster to facilitate international expansion and support the needs of the local and global market.

ASBIS Enterprises Plc is a leading Value-Added Distributor, developer, and supplier of IT and IoT products, solutions, and services in the growing markets of Europe, Middle East, and Africa. ASBIS has a long-standing interest in the biotechnology and healthcare sectors and their own Perenio brand even includes a Smart Health division that is focused on innovative solutions for personal health.